Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

5

Revenue 2014

Lantus

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lantus was produced by Sanofi.

Samsung deal with Takeda looks beyond biosimilars

Samsung deal with Takeda looks beyond biosimilars

Samsung Bioepis has already been granted approvals for biosimilars of Amgen's Enbrel (etanercept), Johnson &Johnson's Remicade (infliximab) and Sanofi's Lantus (insulin glargine), and has filed for versions of

Solid start for Dupixent as Sanofi raises 2017 outlook

Solid start for Dupixent as Sanofi raises 2017 outlook offsetting declines for its cardiovascular drugs and a 19% drop in sales of Lantus (insulin glargine) to 1.20bn. ... Lantus is Sanofi's biggest-selling drug but has been hit by biosimilar competition, and the company is expecting the pace of decline to

Novo says real-world data backs its insulin switching

Novo says real-world data backs its insulin switching It showed that switching to Tresiba (insulin from another basal insulin - mainly Sanofi's Lantus (insulin glargine U100) or Novo's own Levemir (insulin detemir) brand - improved blood glucose control and ... Lantus was found to be neutral on

Novo says real-world data back its insulin switching

Novo says real-world data back its insulin switching It showed that switching to Tresiba (insulin from another basal insulin - mainly Sanofi's Lantus (insulin glargine U100) or Novo's own Levemir (insulin detemir) brand - improved blood glucose control and ... Lantus was found to be neutral on

Novo Nordisk's long-acting haemophilia B drug cleared by FDA

Novo Nordisk's long-acting haemophilia B drug cleared by FDA likely to cause low blood sugar levels or hypoglycaemia in patients with type 2 diabetes compared to Sanofi's Lantus.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 is a global healthcare technology company and an effective digital communications platform, which is supported by strong communities and...

Latest intelligence

Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...
So how do you really engage with patients?
The most valuable insights from patient engagement are the most unexpected ones. Simple things, which may seem unimportant to you, may be the key to making patients’ lives easier and...
data
Avoiding data pitfalls in clinical research
Genomics sequencing and sensors will present new challenges...

Infographics